Drug Profile


Alternative Names: Albarel; Hyperdix; Hyperium; Hyperlex; Iperdix; Iterium; S-3341; Tenaxum

Latest Information Update: 14 Apr 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Servier
  • Class Centrally-acting antihypertensives; Oxazoles; Small molecules
  • Mechanism of Action Alpha 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Hypertension

Most Recent Events

  • 20 Mar 2005 A study has been added to the Hypertension therapeutic trials section
  • 10 Dec 1999 Launched for Hypertension in Czech Republic (PO)
  • 10 Dec 1999 Launched for Hypertension in Hungary (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top